Mikhail Naum Kosiborod
70PUBLICATIONS
254CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (70)
Sort by Publication Date:
|Nov 04, 2024
Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2).Sean Wharton, Carel W le Roux, Mikhail N Kosiborod
|Oct 18, 2024
Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction.Senthil Selvaraj, Shachi Patel, Andrew J Sauer
|Aug 30, 2024
Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE Trials.Kieran F Docherty, Ruben Buendia Lopez, Folke Folkvaljon
|Jun 27, 2024
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial.Muthiah Vaduganathan, Christopher P Cannon, Meg J Jardine
|May 13, 2024
Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.Sanjiv J Shah, Kavita Sharma, Barry A Borlaug
Pageof 12
Frequent Collaborators
19 joint publications
John J V McMurray
16 joint publications
Sanjiv J Shah
15 joint publications
Scott D Solomon
15 joint publications
Pardeep S Jhund
15 joint publications
Rudolf A de Boer
15 joint publications
Silvio E Inzucchi
11 joint publications
Carolyn S P Lam
10 joint publications
Felipe Martinez
9 joint publications
Subodh Verma
8 joint publications
Piotr Ponikowski